Figure 3.
Management of patients with CRS and/or cardiotoxicity. Proposed algorithm for the management of high-risk cardiac patients who develop CRS and/or cardiotoxicity during treatment with T-cell–directed therapy. ACLS, advanced cardiac life support; ECG, electrocardiography; GDMT, guideline-directed medical therapy.